|
How many volunteers were present at the Congress? : |
200 |
|
Delegates from which countries presented in the congress? : |
Usa, Canada, Iran, Australia, Africa, India, Egypt, Sweden |
|
Were the delegates of any other organizations present in the congress? : |
No |
|
If yes, please write the names of the organizations in the box : |
|
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
I presented evidence showing that endotoxemia-induced inflammatory tachycardia might be linked to a direct action of prostanoids on the cardiac pacemaker cells due to the fact that systemic inflammation may uncouple of cardiac pacemaker from cholinergic neural control in experimental animals. However, we studied the role of prostanoids in this modulation of atrial chronotropic hyporesponsiveness to cholinergic stimulation in endotoxemic rats. They asked if we studied the role of different serotonergic receptors in our project. |
|
If you met staff members, please list their full names & positions. : |
Dr. Ali Keshavarsian, Rush Univ. Medical center,
Dr. Khashayarsha Khazaie, Mayo Clinic, College of Medicine and Graduate School, Usa |
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
No follow up actions required. As a matter of fact it was a good apportunity for me as a cardiovascular pharmacology graduate that had nutrition background to attend a congress focused on disease specific topic including immunology, metabolic and neurological disorders, micrbiome management and food pharma interactions. |
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
Getting visa was the most time consuming process. |
|
Please give a briefing of your own observations and outcomes of the congress: : |
This congress focused on aspects of molecular characteristics of food ingredients towards clinical effectiveness and relevance. This meeting represents an innovative scientific platform totally dedicated to unique and challenging interface between nutrition and pharmacology. The meeting focused on disease specific topic including immunology, metabolic and neurological disorders, micrbiome management and food pharma interactions. The presentation by Dr. Marette showed that omega-3 fatty acids are potent suppressors of inflammation and protects from type2 diabetes through novel glucoregulatory mechanism, and thus may be used in combination with statins to reduce cardiovascular outcomes in obese dyslipidemic subjects. The growing evidence that the gut microbiota is a key determinant of diet-induced obesity and type2 diabetes was discussed. he showed evidence that new polyphenol-rich extracts from cranberry and other wild berries can protect against obesity and type2 diabetes and non-alcohol fatty-liver disease.in high fat-fed mice. |